A Study of Bevonescein in Patients Undergoing Abdominopelvic Surgery

NCT06662097 · Status: RECRUITING · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 64

Last updated 2024-10-28

No results posted yet for this study

Summary

Feasibility study of Bevonescein to highlight Nerves and Ureter in patients undergoing Minimally Invasive Surgery

Conditions

  • Surgery
  • Nerve Injury
  • Imaging

Interventions

DRUG

Bevonescein

Bevonescein is a sterile solution that is intravenously administered

Sponsors & Collaborators

  • Alume Biosciences, Inc.

    lead INDUSTRY

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SEQUENTIAL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-10-16
Primary Completion
2025-06-30
Completion
2025-09-30
FDA Drug
Yes

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06662097 on ClinicalTrials.gov